Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Share this content:

Gemcitabine, Cisplatin, and Sunitinib (GC-S) as Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer

Sponsors and Collaborators
Pfizer

Contact
Dean Bajorin, MD     
646-422-4333
    
Robert Motzer, MD     
646-422-4312     

Investigator
Dean Bajorin, MD     
Memorial Sloan-Kettering Cancer Center

ClinicalTrials.gov Identifier
NCT00847015

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.